These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 27824133)
41. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19). Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK; Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640 [TBL] [Abstract][Full Text] [Related]
42. Snake venomics and venom gland transcriptomic analysis of Brazilian coral snakes, Micrurus altirostris and M. corallinus. Corrêa-Netto C; Junqueira-de-Azevedo Ide L; Silva DA; Ho PL; Leitão-de-Araújo M; Alves ML; Sanz L; Foguel D; Zingali RB; Calvete JJ J Proteomics; 2011 Aug; 74(9):1795-809. PubMed ID: 21515432 [TBL] [Abstract][Full Text] [Related]
43. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms. Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162 [TBL] [Abstract][Full Text] [Related]
44. Current treatment for venom-induced consumption coagulopathy resulting from snakebite. Maduwage K; Isbister GK PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841 [TBL] [Abstract][Full Text] [Related]
45. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies. Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ; Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016 [TBL] [Abstract][Full Text] [Related]
46. Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakes. Ledsgaard L; Wade J; Jenkins TP; Boddum K; Oganesyan I; Harrison JA; Villar P; Leah RA; Zenobi R; Schoffelen S; Voldborg B; Ljungars A; McCafferty J; Lomonte B; Gutiérrez JM; Laustsen AH; Karatt-Vellatt A Nat Commun; 2023 Feb; 14(1):682. PubMed ID: 36755049 [TBL] [Abstract][Full Text] [Related]
47. North American coral snake antivenin for the neutralization of non-native elapid venoms in a murine model. Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF Acad Emerg Med; 2006 Feb; 13(2):121-6. PubMed ID: 16436788 [TBL] [Abstract][Full Text] [Related]
48. [Green mamba venom, a therapeutic promise in polycystic kidney disease]. Jahan C; Robin P Med Sci (Paris); 2018 Nov; 34(11):1006-1008. PubMed ID: 30526843 [No Abstract] [Full Text] [Related]
49. Fatal presumed tiger snake (Notechis scutatus) envenomation in a cat with measurement of venom and antivenom concentration. Padula AM; Winkel KD Toxicon; 2016 Apr; 113():7-10. PubMed ID: 26836396 [TBL] [Abstract][Full Text] [Related]
50. Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy - Australian Snakebite Project (ASP-25). Johnston CI; Ryan NM; O'Leary MA; Brown SG; Isbister GK Clin Toxicol (Phila); 2017 Feb; 55(2):115-122. PubMed ID: 27903075 [TBL] [Abstract][Full Text] [Related]
51. Production and characterization of monoclonal antibodies against Naja naja atra cobrotoxin. Stiles BG; Lidgerding BC; Sexton FW; Guest SB Toxicon; 1991; 29(10):1195-204. PubMed ID: 1724806 [TBL] [Abstract][Full Text] [Related]
52. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209 [TBL] [Abstract][Full Text] [Related]
53. Black mamba dendroaspis polylepis bite: a case report. Závada J; Valenta J; Kopecký O; Stach Z; Leden P Prague Med Rep; 2011; 112(4):298-304. PubMed ID: 22142525 [TBL] [Abstract][Full Text] [Related]
54. The in vitro neuromuscular activity of Indo-Pacific sea-snake venoms: efficacy of two commercially available antivenoms. Chetty N; Du A; Hodgson WC; Winkel K; Fry BG Toxicon; 2004 Aug; 44(2):193-200. PubMed ID: 15246769 [TBL] [Abstract][Full Text] [Related]
55. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology. Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814 [TBL] [Abstract][Full Text] [Related]
56. Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom. Méndez I; Gutiérrez JM; Angulo Y; Calvete JJ; Lomonte B Toxicon; 2011 Nov; 58(6-7):558-64. PubMed ID: 21924279 [TBL] [Abstract][Full Text] [Related]
57. Envenomation by a western green mamba (Dendroaspis viridis) - A report of three episodes in Switzerland. Fuchs J; Weiler S; Meier J Toxicon; 2019 Oct; 168():76-82. PubMed ID: 31254601 [TBL] [Abstract][Full Text] [Related]
58. Venomics of Naja sputatrix, the Javan spitting cobra: A short neurotoxin-driven venom needing improved antivenom neutralization. Tan NH; Wong KY; Tan CH J Proteomics; 2017 Mar; 157():18-32. PubMed ID: 28159706 [TBL] [Abstract][Full Text] [Related]
59. Proteomics and antivenomics of Papuan black snake (Pseudechis papuanus) venom with analysis of its toxicological profile and the preclinical efficacy of Australian antivenoms. Pla D; Bande BW; Welton RE; Paiva OK; Sanz L; Segura Á; Wright CE; Calvete JJ; Gutiérrez JM; Williams DJ J Proteomics; 2017 Jan; 150():201-215. PubMed ID: 27650695 [TBL] [Abstract][Full Text] [Related]
60. Successful use of camelid (alpaca) antivenom to treat a potentially lethal tiger snake (Notechis scutatus) envenomation in a dog. Padula AM; Winkel KD Toxicon; 2016 May; 114():59-64. PubMed ID: 26930223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]